<DOC>
	<DOCNO>NCT01782092</DOCNO>
	<brief_summary>The purpose study ( 15-subject prospective case series ) examine effect Activator Methods technique decrease A1c level patient type II Diabetes Mellitus ( aka adult-onset diabetes ) .</brief_summary>
	<brief_title>Activator Type II Diabetics</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Subjects eligible participate study age 3060 clinically diagnose Type II diabetes primary care provider endocrinologist ( diagnosis usually base FPG &gt; 126 mg/dL two occasion ) . Participants must diagnose least one year currently medical supervision disease . They must also A1c measurement 7 % , indicate less optimal management disease . The study exclude pregnant woman ; comorbidities affect life expectancy ( e.g . malignancy , CVD ) ; uncontrolled hypertension ( &gt; 150/100 mmHg ) ; serious trauma ( e.g . MVA ) within previous 12 month ; diagnose bleeding/clotting disorder ; currently chiropractic care contraindication Activator care ( e.g . vertebral fracture , infection , active inflammatory arthritis , severe osteoporosis ) . The presence exclusion determine history exam procedure . All female subject ask take precaution participation study avoid become pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>diabetes</keyword>
</DOC>